Iron Oxide Nanotubes for Magnetically Guided Delivery and pH Activated Release of Insoluble Anticancer Drugs

Magnetic delivery system has gained significant attention in anticancer therapy. Traditionally, magnetic nanoparticles are encapsulated into other polymer particles, acting as functional material for target delivery. However, these complexes are still associated with poor drug loading efficiency, especially for insoluble anticancer drugs, which are the major component of new chemical entities generated for anticancer use.

Herein, we attempt to develop an iron oxide nanoparticle-based multifunctional system. To screen for appropriate ship, we perform PEG coating and compare the feasibility of spherical and rod-like iron oxide nanoparticles in a view of carcinoma cellular uptake; rod-like nanoparticles attracted our interest since they could be quickly and massively internalized. For insoluble anticancer drug paclitaxel (PTX) loading, we next transform the nanorods into a tube structure by a hydrothermal method. The results show that drug crystals can be successfully loaded in the inner voids of these nanotubes (PMNTs) by controlling the crystallization process of PTX. The acquired nanocomplexes not only escape phagocytosis of macrophage cells by a PEG stealth effect, but also exhibit an increased cellular uptake with magnetic field exposure. In addition, this iron oxide-based drug carrier possesses a low pH-activated release profile, which would accelerate drug release in the carcinoma cells and minimize non-specific drug release. Owing to these advantages, PMNTs promote the anticancer efficacy of PTX and clearly exhibit promising potential for using as high-efficiency insoluble drug delivery system in clinical applications.